Literature DB >> 24495504

Long-term prognosis and clinical characteristics of young adults (≤40 years old) who underwent percutaneous coronary intervention.

Hirokazu Konishi1, Katsumi Miyauchi2, Takatoshi Kasai1, Shuta Tsuboi1, Manabu Ogita1, Ryo Naito1, Yoshiteru Katoh1, Iwao Okai1, Hiroshi Tamura1, Shinya Okazaki1, Hiroyuki Daida1.   

Abstract

BACKGROUND: Limited data exist regarding the long-term prognosis of percutaneous coronary intervention (PCI) in young adults. The aim of this study was to retrospectively assess the long-term clinical outcomes in young patients who underwent PCI. METHODS AND
RESULTS: Between 1985 and 2011, 7649 consecutive patients underwent PCI, and data from 69 young adults (age ≤40 years) and 4255 old adults (age ≧65 years) were analyzed. A Cox proportional hazards regression analysis was used to determine the independent predictors of a composite endpoint that included all-cause death and acute coronary syndrome (ACS) during the follow-up period. The mean age of the 69 young patients was 36.1±4.9 years, and 96% of them were men. Approximately 30% were current smokers, and their body mass index (BMI) was 26.7±5.0kg/m(2). The prevalence of diabetes and hypertension was 33% and 48%, respectively. All patients had ≥1 conventional cardiovascular risk factor. At a median follow-up of 9.8 years, the overall death rate was 5.8%, and new-onset ACS occurred in 8.7%. Current smoking was an independent predictor of the composite endpoint (hazard ratio 4.46, confidence interval 1.08-19.1, p=0.04) for young adults.
CONCLUSION: Current smoking and obesity (high BMI) are the important clinical characteristics in young Japanese coronary heart disease patients who undergo PCI. The long-term prognosis in young patients is acceptable, but current smoking is a significant independent predictor of death and the recurrence of ACS in young Japanese coronary heart disease patients who are obese.
Copyright © 2014 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Long-term prognosis; Percutaneous coronary intervention; Smoking; Young adult

Mesh:

Year:  2014        PMID: 24495504     DOI: 10.1016/j.jjcc.2013.12.005

Source DB:  PubMed          Journal:  J Cardiol        ISSN: 0914-5087            Impact factor:   3.159


  6 in total

1.  Illness Perceptions in Patients with Premature Coronary Artery Disease: A Sex-Based Analysis 8 Years After the Diagnosis.

Authors:  Masoumeh Lotfi-Tokaldany; Abbasali Karimi; Nazila Shahmansouri; Saeed Sadeghian; Seyed Hesameddin Abbasi; Arash Jalali; Farah Ayatollahzade Isfahani; Soheil Saadat
Journal:  J Clin Psychol Med Settings       Date:  2019-06

Review 2.  Epidemiology of cardiovascular disease in young individuals.

Authors:  Charlotte Andersson; Ramachandran S Vasan
Journal:  Nat Rev Cardiol       Date:  2017-10-12       Impact factor: 32.419

Review 3.  Newer perspectives of coronary artery disease in young.

Authors:  Amitesh Aggarwal; Saurabh Srivastava; M Velmurugan
Journal:  World J Cardiol       Date:  2016-12-26

4.  Outcomes of Coronary Artery Bypass Graft Surgery Versus Percutaneous Coronary Intervention in Patients Aged 18-45 Years with Diabetes Mellitus.

Authors:  Yang Li; Ran Dong; Kun Hua; Tao-Shuai Liu; Shao-You Zhou; Ning Zhou; Hong-Jia Zhang
Journal:  Chin Med J (Engl)       Date:  2017-12-20       Impact factor: 2.628

5.  Comparative assessment of clinical profile and outcomes after primary percutaneous coronary intervention in young patients with single vs multivessel disease.

Authors:  Atif Sher Muhammad; Tariq Ashraf; Ayaz Mir; Syed Alishan; Faiza Farooq; Ali Ammar; Musa Karim; Syed Nadeem Hassan Rizvi; Tahir Saghir; Jawaid Akbar Sial; Naveed Ullah Khan
Journal:  World J Cardiol       Date:  2020-04-26

6.  The association of religious affiliation with cholesterol levels among South Asians: the Mediators of Atherosclerosis in South Asians Living in America study.

Authors:  Grishma Hirode; Eric Vittinghoff; Nazleen H Bharmal; Namratha R Kandula; Alka M Kanaya
Journal:  BMC Cardiovasc Disord       Date:  2019-03-29       Impact factor: 2.298

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.